Suprema HQ Inc. (094840.KQ)
- Previous Close
9,300.00 - Open
0.00 - Bid --
- Ask --
- Day's Range
0.00 - 0.00 - 52 Week Range
0.00 - 9,690.00 - Volume
0 - Avg. Volume
368,099 - Market Cap (intraday)
75.334B - Beta (5Y Monthly) 0.69
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 12, 2025 - May 16, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Dec 28, 2011
- 1y Target Est
--
Suprema HQ Inc. manufactures and sells of access control, time and attendance, and biometrics solutions worldwide. The company offers BioStar 2 access control, a security platform; BioStar 2 TA is a time and attendance module that serves as an add-on for the BioStar 2 platform; Suprema Mobile Access that allows user's smartphone as a key to access doors, facilities, and other accesses; and Suprema CLUe, an open cloud integration platform. It provides biometric and RF/mobile readers and intelligent controllers; and peripherals, including thermal cameras, input and output modules, secure and door modules, as well as OEM fingerprint modules. In addition, the company offers NOVUS, an open platform, designed for use in any time and attendance or workforce management application. It serves the construction, data center, healthcare, commercial, infrastructure, and manufacturing industries. The company was formerly known as Suprema Inc. and changed its name to Suprema HQ Inc. in February 2016. The company was founded in 2000 and is headquartered in Seongnam-si, South Korea.
www.supremainc.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Scientific & Technical Instruments
Industry
Recent News: 094840.KQ
View MorePerformance Overview: 094840.KQ
Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 094840.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 094840.KQ
View MoreValuation Measures
Market Cap
75.33B
Enterprise Value
16.27B
Trailing P/E
4.98
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.77
Price/Book (mrq)
0.34
Enterprise Value/Revenue
0.81
Enterprise Value/EBITDA
0.92
Financial Highlights
Profitability and Income Statement
Profit Margin
75.68%
Return on Assets (ttm)
0.67%
Return on Equity (ttm)
7.06%
Revenue (ttm)
20.1B
Net Income Avi to Common (ttm)
15.21B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
59.07B
Total Debt/Equity (mrq)
0.00%
Levered Free Cash Flow (ttm)
-9.35B